분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2011-05-17 13:01:49 , Hit : 2943
 Sugars recruited in fight against persistent infections

12 May 2011


Adding sugar to antibiotics can boost their effectiveness and prevent recurrent and chronic infections, according to researchers in the US. A similar strategy could be used to treat tuberculosis (TB) in the developing world where persistent infections are a real problem, they say.

Bacterial persisters - dormant cells that can tolerate antibiotic treatments - account for less than one per cent of bacterial cells. But after a course of antibiotics they can multiply, causing the infection to return.

A team led by James Collins at the University of Boston in the US, has been looking at ways to kill bacterial persisters by adding sugars to aminoglycoside antibiotics. 'Most antibiotics work against growing bacterial cells', says Collins. 'We thought we could trigger the bacterial persisters with sugars or metabolites to get them to grow, and then kill them with the antibiotics.'

The team investigated the effect of a number of sugars combined with gentamicin, an aminoglycoside, on Staphylococcus aureus or Escherichia coli  by labelling the antibiotic with a red fluorescent dye. They then analysed the bacteria using fluorescence-activated cell sorting. The team found that the sugars led the bacteria to take up the antibiotic, killing a high proportion of them.

Collins explains that when the bacteria were treated with gentamicin and sugars, such as mannitol, fructose or glucose, the bacterial persisters did not start growing again, but still died. The researchers theorise that, instead of promoting growth, the sugars alter the electrochemical gradient in the bacteria, allowing the antibiotic in.

The sugar-antibiotic combination was successfully tested on bacterial biofilms - populations of bacteria, encapsulated in a polysaccharide matrix, that are extremely difficult to kill. They also treated mice with urinary tract infections using their sugar-antibiotic combination.

'This strategy could find application not only in the treatment of urinary tract infections, but a variety of biofilm-associated infections or diseases. It is therefore of great significance,' says Sylvie Garneau-Tsodikova, an aminoglycosides expert at the University of Michigan, US. 'It will be interesting to see how new, more potent and less toxic aminoglycosides that were just discovered, or that will be developed in the future, will fair in killing bacterial persisters using this methodology,' she adds.

Collins believes the next step is to explore a similar strategy to treat TB. 'The method is simple and inexpensive and should also be amenable, as we take it further into clinical trials, for production in the developing world,' he says. 'You can have your existing antibiotics and just add sugars, that are cheap, to boost the effectiveness of the treatment.'

Mike Brown



Interesting? Spread the word using the 'tools' menu on the left.

ReferencesJ Collins et al, Nature, 2011, 473, 216 (DOI: 10.1038/nature10069)







907   Stem Cells of 10-Year-Old Help Create Blood Vessel in Life-Saving Surgery  이성욱 2011/05/11 2669
906   Foot-and-mouth culls could be cut  이성욱 2011/05/11 3182
905   HIV Drug Could Prevent Cervical Cancer, Researchers Discover  이성욱 2011/05/12 2525
904   Liver repaired with stem cells taken from skin and blood  이성욱 2011/05/14 2383
903   Merck’s Hepatitis C Drug Wins F.D.A. Approval  이성욱 2011/05/17 2264
902   Setback for New Stem Cell Treatment  이성욱 2011/05/17 2079
  Sugars recruited in fight against persistent infections  이성욱 2011/05/17 2943
900   The dark matter of disease -NC DNA  이성욱 2011/05/18 2555
899   Reprogrammed cells trigger immune reactions in mice  이성욱 2011/05/20 2133
898   Understanding HIV Latency to Undo It  이성욱 2011/05/23 2473
897   WHO to decide fate of smallpox stocks  이성욱 2011/05/24 2475
896   Vertex hepatitis C drug OK'd, promising more cures  이성욱 2011/05/25 2351
895   Stem cells: The growing pains of pluripotency  이성욱 2011/05/25 2112
894   Hepatitis C mouse model a major milestone  이성욱 2011/06/11 2146
893   Vertex licenses Hep C candidates in milestone-heavy deal  이성욱 2011/06/14 2858
892   Protein synthesis: Stop the nonsense  이성욱 2011/06/20 2309
891   HIV study reveals double jeopardy  이성욱 2011/06/26 2663
890   NIH's Secondhand Shop for Tried-and-Tested Drugs  이성욱 2011/06/27 2380
889   RNAs Regulate Cell Death  이성욱 2011/07/07 2540
888   South Korea back in stem cell spotlight with new treatment  이성욱 2011/07/08 2169

[이전 10개] [1]..[11][12][13][14][15][16][17][18] 19 [20]..[64] [다음 10개]
 

Copyright 1999-2023 Zeroboard / skin by ROBIN